Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun;17(4):1239-1241.
doi: 10.1007/s11739-021-02908-4. Epub 2022 Jan 24.

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine

Michele Gilio  1 , Giulio De Stefano  2   3
Affiliations
Case Reports

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine

Michele Gilio et al. Intern Emerg Med. 2022 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Positron emission tomography (PET) that demonstrated an increased fluorodeoxyglucose (FDG) vascular uptake compatible with large-vessels vasculitis
See this image and copyright information in PMC

Comment in

References

    1. World Health Organization. Draft landscape of COVID-19 candidate vaccines. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand.... Accessed 20 Oct 2020
    1. Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–317. doi: 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F. - DOI - PubMed
    1. Hellmich B, Agueda A, Monti S, et al. Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2018;2020(79):19–30. - PubMed
    1. Bonetto C, Trotta F, Felicetti P, et al. Vasculitis as an adverse event following immunization—systematic literature review. Vaccine. 2016;34:6641–6651. doi: 10.1016/j.vaccine.2015.09.026. - DOI - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources